KR102399971B1 - Composition for Silkworm-collagen and manufacturing method thereof - Google Patents
Composition for Silkworm-collagen and manufacturing method thereof Download PDFInfo
- Publication number
- KR102399971B1 KR102399971B1 KR1020190174221A KR20190174221A KR102399971B1 KR 102399971 B1 KR102399971 B1 KR 102399971B1 KR 1020190174221 A KR1020190174221 A KR 1020190174221A KR 20190174221 A KR20190174221 A KR 20190174221A KR 102399971 B1 KR102399971 B1 KR 102399971B1
- Authority
- KR
- South Korea
- Prior art keywords
- silkworm
- collagen
- powder
- weight
- enzyme
- Prior art date
Links
- 229920001436 collagen Polymers 0.000 title claims abstract description 106
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 241000255789 Bombyx mori Species 0.000 claims abstract description 153
- 108010035532 Collagen Proteins 0.000 claims abstract description 105
- 102000008186 Collagen Human genes 0.000 claims abstract description 105
- 239000000843 powder Substances 0.000 claims abstract description 85
- 235000013402 health food Nutrition 0.000 claims abstract description 43
- 102000004190 Enzymes Human genes 0.000 claims abstract description 42
- 108090000790 Enzymes Proteins 0.000 claims abstract description 42
- 241000251468 Actinopterygii Species 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 12
- 229940088598 enzyme Drugs 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 239000004365 Protease Substances 0.000 claims description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000000725 suspension Substances 0.000 claims description 20
- 241000254158 Lampyridae Species 0.000 claims description 16
- 239000000654 additive Substances 0.000 claims description 14
- 108091005804 Peptidases Proteins 0.000 claims description 12
- 102000035195 Peptidases Human genes 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 11
- 229930003268 Vitamin C Natural products 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 11
- 239000011718 vitamin C Substances 0.000 claims description 11
- 235000019154 vitamin C Nutrition 0.000 claims description 11
- 108010004032 Bromelains Proteins 0.000 claims description 10
- 108090000526 Papain Proteins 0.000 claims description 10
- 235000019834 papain Nutrition 0.000 claims description 10
- 229940055729 papain Drugs 0.000 claims description 10
- 235000019835 bromelain Nutrition 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 230000000996 additive effect Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 235000013305 food Nutrition 0.000 abstract description 16
- 230000036541 health Effects 0.000 abstract description 6
- 230000006872 improvement Effects 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 235000019688 fish Nutrition 0.000 description 26
- 239000000243 solution Substances 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- 238000012360 testing method Methods 0.000 description 17
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 108010028144 alpha-Glucosidases Proteins 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 229960000583 acetic acid Drugs 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000003914 insulin secretion Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 230000003178 anti-diabetic effect Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000001694 spray drying Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 150000005846 sugar alcohols Polymers 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 240000000249 Morus alba Species 0.000 description 4
- 235000008708 Morus alba Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000003472 antidiabetic agent Substances 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 2
- IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 4-nitrophenyl alpha-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000255791 Bombyx Species 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 108090000270 Ficain Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- -1 Protamax Proteins 0.000 description 2
- 101710180012 Protease 7 Proteins 0.000 description 2
- 108010013296 Sericins Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 108010077465 Tropocollagen Proteins 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229960002632 acarbose Drugs 0.000 description 2
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 235000019836 ficin Nutrition 0.000 description 2
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012723 sample buffer Substances 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- 241000723298 Dicentrarchus labrax Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001282110 Pagrus major Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000269980 Pleuronectidae Species 0.000 description 1
- 241000244279 Sanicula chinensis Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000012528 insulin ELISA Methods 0.000 description 1
- 206010022498 insulinoma Diseases 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 208000021255 pancreatic insulinoma Diseases 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000001967 plate count agar Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010043393 protease N Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Abstract
본 발명은 누에콜라겐 건강식품 조성물과 이의 제조방법에 관한 것으로, 더욱 상세하게는 누에의 유효성분을 함유하며, 어류에서 추출된 마린콜라겐에 의해 피부개선 및 건강증진 효과를 증대시킬 수 있는 누에콜라겐 건강식품 조성물과 이의 제조방법에 관한 것이다.
본 발명의 누에콜라겐 건강식품 조성물은 누에분말을 효소처리한 효소처리누에분말과, 어류로부터 추출된 마린콜라겐을 함유한다.The present invention relates to a silkworm collagen health food composition and a method for producing the same, and more particularly, to silkworm collagen health containing an active ingredient of silkworm and capable of enhancing skin improvement and health promotion effect by marine collagen extracted from fish It relates to a food composition and a method for preparing the same.
The silkworm collagen health food composition of the present invention contains an enzyme-treated silkworm powder obtained by treating silkworm powder with an enzyme, and marine collagen extracted from fish.
Description
본 발명은 누에콜라겐 건강식품 조성물과 이의 제조방법에 관한 것으로, 더욱 상세하게는 누에의 유효성분을 함유하며, 어류에서 추출된 마린콜라겐에 의해 피부개선 및 건강증진 효과를 증대시킬 수 있는 누에콜라겐 건강식품 조성물과 이의 제조방법에 관한 것이다.The present invention relates to a silkworm collagen health food composition and a manufacturing method thereof, and more particularly, to silkworm collagen health containing active ingredients of silkworm and capable of enhancing skin improvement and health promotion effects by marine collagen extracted from fish. It relates to a food composition and a method for preparing the same.
콜라겐은 동물 체내에 가장 풍부하게 존재하는 단백질로서 체단백질의 약 30% 이상을 차지하며, 최소 19종류(Type Ⅰ-ⅩⅨ) 이상인 것으로 밝혀져 있다. 또한, 콜라겐은 동물의 결합조직의 주요 단백질이며, 조직이나 장기를 지탱하게 하고 체표를 둘러싸고 있어 체형을 유지시키는 역할을 한다. 특히 생체에서 피부, 연골, 뼈 등의 결합조직의 주요한 구성성분으로 40%는 피부, 20%는 뼈와 연골, 그 외 혈관과 내장 등 전신에 넓게 분포되어 있다. Collagen is the most abundant protein in the animal body and accounts for about 30% or more of body protein, and it has been found that there are at least 19 types (Type I-XIX). In addition, collagen is a major protein of connective tissue of animals, supports tissues or organs, and surrounds the body surface, thereby maintaining the body shape. In particular, as a major component of connective tissue such as skin, cartilage, and bone in the living body, 40% is the skin, 20% is the bone and cartilage, and is widely distributed throughout the body such as blood vessels and internal organs.
콜라겐은 2중 나선구조를 하고 있는 근원섬유 단백질과는 달리 3중 나선구조로, 그 직경이 약 14~15nm, 길이는 280~300nm, 평균 분자량은 약 300KDa이며, (Gly-XY)n과 같은 규칙적인 형태의 아미노산 배열을 가지며 섬유상 단백질의 기본단위 분자인 트로포콜라겐(tropocollagen) 분자 내 또는 트로포콜라겐(tropocollagen) 분자 간의 공유결합성 교차결합(crosslinking)에 의해 물리적, 생물학적으로 안정한 구조를 형성하고 있다. Collagen has a triple helix structure, unlike myofibrillar proteins, which have a double helix structure, with a diameter of about 14 to 15 nm, a length of 280 to 300 nm, and an average molecular weight of about 300 KDa. It has a regular amino acid arrangement and forms a physically and biologically stable structure by covalent crosslinking within the tropocollagen molecule, the basic unit molecule of fibrous protein, or between tropocollagen molecules. .
콜라겐은 추출된 원료에 따라 동물성 콜라겐과 마린 콜라겐(해양성 콜라겐, 피쉬콜라겐)으로 구분된다. 소, 닭, 돼지 등에서 추출한 동물성 콜라겐의 경우 열에 강해 가공이 용이하여 일반적으로 널리 이용되고 있으나 분자량이 커 섭취시 인체 흡수성이 높지 않다. 마린콜라겐의 경우 어류에서 추출한 것으로, 동물성 콜라겐과 비교하여 안정성이 높으나, 체내 흡수성이 다소 좋지 못하다. Collagen is divided into animal collagen and marine collagen (marine collagen, fish collagen) according to the extracted raw material. Animal collagen extracted from cows, chickens, and pigs is generally widely used because it is strong against heat and easy to process. In the case of marine collagen, which is extracted from fish, it has high stability compared to animal collagen, but its absorption in the body is rather poor.
한편, 누에(Bombyx mori L.)는 누에나방과에 속하는 누에나방에 유충으로 대량 사육이 가능하며 단백질 함량이 높아 고단백질 식품소재로(Cho, C. H. et al., Effect of temperature, time and pH on the extraction of proteinin a chrysalis of silkworm, Korean J. Biotechnol. Bioeng., 4, P65-68, 1989), 필수 아미노산과 n-3 계열의 고도불포화 지방산 함유량이 높아 간 기능 개선이나 혈액순환 관련 건강식품 소재로 활용 가능성이 제시되고 있다(Seong, S. I. et al., Effect of metamorphois on the major hemolymph proteins of the silkworm, Arch. Insect Biochem. Physiol., 2, P91-104, 1985). On the other hand, silkworm ( Bombyx mori L. ) is a larva of the Bombyx moth belonging to the family Bombyx mori, which can be mass-bred and has a high protein content, making it a high-protein food material (Cho, CH et al., Effect of temperature, time and pH on the extraction of proteinin a). chrysalis of silkworm, Korean J. Biotechnol. Bioeng., 4, P65-68, 1989), high in essential amino acids and n-3 polyunsaturated fatty acids (Seong, SI et al., Effect of metamorphois on the major hemolymph proteins of the silkworm, Arch. Insect Biochem. Physiol., 2, P91-104, 1985).
또 누에실크 유래의 sericin 단백질도 serine, asparticacid 및 glycine으로 주로 구성되어 있어 간 보호 효과와 항산화 효과가 높은 것으로 보고되었다.(Kato, N. etal., Silk protein, sericin, inhibits lipid peroxidation and tyrosinase activity, Biosci. Biotechnol.Biochem., 62, P145-147, 1998). In addition, the sericin protein derived from silkworm mainly consists of serine, asparticacid and glycine, and it has been reported to have high hepatoprotective and antioxidant effects (Kato, N. et al., Silk protein, sericin, inhibits lipid peroxidation and tyrosinase activity, Biosci. Biotechnol. Biochem., 62, P145-147, 1998).
또한 단백질 함량이 높은 누에 분말을 Bacillus속 미생물로 발효시켜 얻은 발효누에에서 항산화 작용, 혈전용해 작용, 티로시나제 활성 저해 등의 생리활성작용이 발효 전 누에 분말보다 증가하는 것으로 보고한 바 있다. (Cha, J. Y. et al., Biological activity of fermented silkworm powder, J. Life Sci., 19, P1468-1477, 2009) In addition, it has been reported that physiological activities such as antioxidant action, thrombolytic action, and inhibition of tyrosinase activity in fermented silkworms obtained by fermenting silkworm powder with high protein content with microorganisms of the genus Bacillus are increased compared to silkworm powder before fermentation. (Cha, J. Y. et al., Biological activity of fermented silkworm powder, J. Life Sci., 19, P1468-1477, 2009)
그러나 종래에 열풍건조나 동결건조만으로 제조한 누에 분말의 경우 누에의 유효성분에 의한 효과를 얻기 어렵다는 단점이 있다.However, in the case of silkworm powder prepared only by hot air drying or freeze-drying in the prior art, there is a disadvantage in that it is difficult to obtain the effect by the active ingredient of silkworm.
대한민국 등록특허공보 제10-1636680호에는 어류 유래 저분자 콜라겐 펩타이드의 제조방법이 개시되어 있으며, 대한민국 등록특허공보 제10-1918759호에 누에 동결건조 분말을 이용한 가공식품 및 그 제조방법이 개시되어 있으나, 본 발명에서와 같이 '누에콜라겐 건강식품 조성물'에 관해서는 밝혀진 바가 없다. Korean Patent No. 10-1636680 discloses a method for producing a low molecular weight collagen peptide derived from fish, and Korean Patent Publication No. 10-1918759 discloses a processed food using lyophilized silkworm powder and a method for manufacturing the same, As in the present invention, nothing has been revealed about the 'silkworm collagen health food composition'.
본 발명은 상기와 같은 문제점을 해결하기 위한 것으로, 효소처리누에분말과 마린콜라겐을 함유하여 건강 증진효과를 높일 수 있으며, 누에의 효소분해물 유래의 펩타이드가 작용하여 콜라겐의 체내흡수율을 높일 수 있는 누에콜라겐 건강식품 조성물을 제공하는 것에 목적이 있다.The present invention is to solve the above problems, and contains enzyme-treated silkworm powder and marine collagen to enhance health promotion effect, and the peptide derived from the enzyme decomposition product of silkworm acts to increase the absorption rate of collagen in the body. It is an object to provide a collagen health food composition.
상기와 같은 목적을 달성하기 위한 본 발명의 누에콜라겐 건강식품 조성물은 누에분말을 효소처리한 효소처리누에분말과, 어류로부터 추출된 마린콜라겐을 함유한다.The silkworm collagen health food composition of the present invention for achieving the above object contains enzyme-treated silkworm powder obtained by enzymatically treating silkworm powder, and marine collagen extracted from fish.
또한, 비타민C와 첨가물을 더 함유하고, 상기 효소처리누에분말 20 내지 50 중량%, 상기 마린콜라겐 5 내지 40중량%, 상기 비타민C 1 내지 10중량%, 상기 첨가물 30 내지 60중량%를 함유한다. In addition, it further contains vitamin C and additives, and contains 20 to 50% by weight of the enzyme-treated silkworm powder, 5 to 40% by weight of the marine collagen, 1 to 10% by weight of the vitamin C, and 30 to 60% by weight of the additives. .
상기 첨가물은 참반디 추출물이다.The additive is a firefly extract.
그리고 상기와 같은 목적을 달성하기 위한 본 발명의 누에콜라겐 건강식품 조성물의 제조방법은 누에분말을 효소처리하여 효소처리누에분말을 수득하는 제 1단계와; 어류로부터 추출된 마린콜라겐을 준비하는 제 2단계와; 상기 효소처리누에분말과 상기 마린콜라겐을 혼합하는 제 3단계;를 포함하고, 상기 제 1단계는 a)누에를 동결건조시켜 100 내지 300메쉬 입도 크기의 상기 누에분말을 얻는 단계와, b)상기 누에분말을 물에 현탁하여 누에현탁액을 제조하는 단계, c)상기 누에현탁액에 단백질 분해효소를 첨가하여 40 내지 70℃에서 1 내지 2일간 가수분해시켜 가수분해물을 수득하는 단계, d)상기 가수분해물을 분무건조시켜 효소처리누에분말을 수득하는 단계를 구비한다.And the manufacturing method of the silkworm collagen health food composition of the present invention for achieving the above object comprises: a first step of enzymatically treating the silkworm powder to obtain an enzyme-treated silkworm powder; a second step of preparing marine collagen extracted from fish; A third step of mixing the enzyme-treated silkworm powder with the marine collagen, wherein the first step includes: a) freeze-drying the silkworm to obtain the silkworm powder having a particle size of 100 to 300 mesh; b) the preparing a silkworm suspension by suspending silkworm powder in water, c) adding a proteolytic enzyme to the silkworm suspension to hydrolyze it at 40 to 70° C. for 1 to 2 days to obtain a hydrolyzate, d) the hydrolyzate and spray-drying to obtain an enzyme-treated silkworm powder.
상기 단백질 분해효소로서 상기 누에현탁액 100중량부에 대하여 브로멜라인 0.5중량부와, 파파인 1.0중량부를 첨가한다.As the proteolytic enzyme, 0.5 parts by weight of bromelain and 1.0 parts by weight of papain are added with respect to 100 parts by weight of the silkworm suspension.
상기 혼합단계는 비타민C와 첨가물을 더 혼합하며, 상기 첨가물은 참반디 추출물이다. In the mixing step, vitamin C and additives are further mixed, and the additive is a firefly extract.
상술한 바와 같이 본 발명의 누에콜라겐 건강식품 조성물은 누에분말을 효소처리한 효소처리누에분말과, 어류로부터 추출된 마린콜라겐을 함유하여 당뇨 개선 등 건강증진에 유용하다. As described above, the silkworm collagen health food composition of the present invention contains enzyme-treated silkworm powder obtained by enzymatic treatment of silkworm powder, and marine collagen extracted from fish, and is useful for improving health, such as diabetes.
아울러 본 발명의 누에콜라겐 건강식품 조성물은 섭취 시, 효소처리누에분말의 펩타이드가 작용하여 콜라겐의 체내흡수율을 높일 수 있다. In addition, when the silkworm collagen health food composition of the present invention is ingested, the peptide of the enzyme-treated silkworm powder acts to increase the absorption rate of collagen in the body.
도 1은 단백질 분해효소의 종류에 따른 효소처리누에분말의 SDS-PAGE를 나타내는 이미지이고,
도 2는 세포 생존율 평가 실험결과를 나타내는 표이고,
도 3은 α-glucosidase의 저해 활성 평가 실험결과를 나타내는 표이고,
도 4는 인슐린 분비능 평가 실험결과를 나타내는 표이고,
도 5는 도 4의 실험결과를 나타낸 그래프이고,
도 6은 본 발명의 누에콜라겐 건강식품 조성물을 나타낸 사진이고,
도 7은 본 발명의 누에콜라겐 건강식품 조성물의 수용성 실험결과를 나타낸 사진이다. 1 is an image showing SDS-PAGE of enzyme-treated silkworm powder according to the type of proteolytic enzyme;
Figure 2 is a table showing the cell viability evaluation experimental results,
3 is a table showing the results of the evaluation of the inhibitory activity of α-glucosidase,
4 is a table showing the results of the insulin secretion ability evaluation experiment,
Figure 5 is a graph showing the experimental results of Figure 4,
6 is a photograph showing the silkworm collagen health food composition of the present invention,
7 is a photograph showing the water solubility test result of the silkworm collagen health food composition of the present invention.
이하, 본 발명의 바람직한 실시 예에 따른 누에콜라겐 건강식품 조성물과 이의 제조방법에 대해 상세하게 설명한다.Hereinafter, a silkworm collagen health food composition and a manufacturing method thereof according to a preferred embodiment of the present invention will be described in detail.
본 발명의 일 예에 따른 누에콜라겐 건강식품 조성물은 누에분말을 효소처리한 효소처리누에분말과, 어류로부터 추출된 마린콜라겐을 함유한다. 가령, 누에콜라겐 건강식품 조성물은 효소처리누에분말 1 내지 90중량%, 마린콜라겐 1 내지 90중량%로 구성될 수 있다.The silkworm collagen health food composition according to an embodiment of the present invention contains enzyme-treated silkworm powder obtained by enzymatically treating silkworm powder, and marine collagen extracted from fish. For example, the silkworm collagen health food composition may be composed of 1 to 90% by weight of enzyme-treated silkworm powder, and 1 to 90% by weight of marine collagen.
효소처리누에분말은 누에분말을 효소처리한 것이다.Enzyme-treated silkworm powder is an enzyme-treated silkworm powder.
누에(Bombyx mori)는 누에나방과에 속하는 누에나방에 유충으로서, 뽕잎을 먹고 자라며 튼튼한 고치를 만들어 번데기가 된다. 몸통은 원통형이며, 머리·가슴·배의 세 부분으로 되어 있다. 직사광선을 싫어하고 몸은 젖빛을 띠며 연한 키틴질 껍질로 덮여 있어 부드러운 감촉을 준다. 알에서 부화되어 나왔을 때 누에의 크기는 약 3mm이며, 털이 많고 검은 빛깔을 띤다. 누에는 뽕잎을 먹으면서 성장하고, 4령잠을 자고 5령이 되면 급속하게 자라서 8cm 정도가 된다. 5령 말까지의 유충기간 일수는 보통 20일 내외이다. 5령 말이 되면 뽕잎 먹는 것을 멈추고 고치를 짓기 시작한다. Silkworm ( Bombyx ) mori ) is a larva of the silkworm moth belonging to the family Silkworm moth, and it grows by eating mulberry leaves to make a strong cocoon and pupate. The body is cylindrical and consists of three parts: head, chest, and abdomen. It hates direct sunlight, and its body is milky and covered with a soft chitinous shell, giving it a soft touch. When hatched from an egg, the size of the silkworm is about 3mm, and it is hairy and has a black color. Silkworms grow while eating mulberry leaves, sleep at 4 instars, and grow rapidly when they reach 5 instars, reaching 8cm. The larval period until the end of the fifth instar is usually around 20 days. At the end of the fifth instar, they stop eating mulberry leaves and start making cocoons.
누에는 1-데옥시노지리마이신(1-deoxynojirimycine,DNJ)을 함유하고 있으며, 1-데옥시노지리마이신은 혈당 강하, 항바이러스 및 암세포 전이방지 효능이 있다. 이 밖에도 누에는 간 독성 회복 효과와 변비개선효과가 있으며, 뇌기능 개선효과, 노화지연 효과 등 다양한 효능을 가지고 있다. Silkworm contains 1-deoxynojirimycine (DNJ), and 1-deoxynojirimycin is effective in lowering blood sugar, antiviral and cancer cell metastasis. In addition, silkworm has various effects such as liver toxicity recovery effect and constipation improvement effect, brain function improvement effect and aging delay effect.
누에분말을 효소처리한 효소처리누에분말은 200 내지 400메쉬 입도 크기로 형성될 수 있다. Enzyme-treated silkworm powder obtained by enzymatically treating silkworm powder may be formed in a particle size of 200 to 400 mesh.
마린콜라겐은 어류로부터 추출된 콜라겐이다. 마린콜라겐은 상업화된 분말 제품을 구입하여 이용하거나, 어류로부터 직접 추출하여 이용할 수 있다. 일 예로 어류의 부산물인 어피로부터 마린콜라겐을 추출할 수 있다. Marine collagen is collagen extracted from fish. Marine collagen can be used by purchasing a commercial powder product or directly extracted from fish. For example, marine collagen may be extracted from the fish skin, which is a by-product of fish.
마린콜라겐은 200 내지 400메쉬 입도 크기의 분말 형태로 이용한다. Marine collagen is used in powder form with a particle size of 200 to 400 mesh.
본 발명의 누에콜라겐 건강식품 조성물은 누에분말을 효소처리한 효소처리누에분말과, 어류로부터 추출된 마린콜라겐을 함유하므로 누에 및 콜라겐에 의한 효능을 동시에 얻을 수 있다. 아울러 본 발명의 누에콜라겐 건강식품 조성물은 섭취 시, 효소처리누에분말의 펩타이드가 작용하여 콜라겐의 체내흡수율을 높일 수 있다. Since the silkworm collagen health food composition of the present invention contains enzyme-treated silkworm powder obtained by enzymatically treating silkworm powder, and marine collagen extracted from fish, the efficacy of silkworm and collagen can be obtained at the same time. In addition, when the silkworm collagen health food composition of the present invention is ingested, the peptide of the enzyme-treated silkworm powder acts to increase the absorption rate of collagen in the body.
본 발명에서 '식품 조성물'이란, 영양소를 한 가지 또는 그 이상 함유하고 있는 천연물 또는 가공품을 의미하며, 바람직하게는 어느 정도의 가공 공정을 거쳐 직접 먹을 수 있는 상태가 된 것을 의미하며, 통상적인 의미로서, 식품, 식품 첨가제, 기능성 식품 및 음료를 모두 포함하는 것을 말한다.In the present invention, 'food composition' means a natural product or processed product containing one or more nutrients, and preferably means a state that can be eaten directly through a certain processing process, and has a conventional meaning As such, it refers to all foods, food additives, functional foods and beverages.
바람직하게 본 발명은 효소처리누에분말과 마린콜라겐을 함유한 건강식품 조성물로 제공될 수 있다. 여기서 '건강식품 조성물'이란 식품에 물리적, 생화학적, 생물공학적 수법 등을 이용하여 해당 식품의 기능을 특정 목적에 작용, 발현하도록 부가가치를 부여한 식품군이나 식품 조성이 갖는 생체방어리듬조절, 질병방지와 회복 등에 관한 체내조절기능을 생체에 대하여 충분히 발현하도록 설계하여 가공한 식품을 의미한다.Preferably, the present invention may be provided as a health food composition containing enzyme-treated silkworm powder and marine collagen. Here, 'health food composition' refers to a food group or food composition that has added added value so that it acts and expresses the function of the food for a specific purpose using physical, biochemical, and bioengineering methods, etc. It refers to food that has been designed and processed to sufficiently express the body control functions related to recovery, etc.
본 발명에 따른 건강식품 조성물로는 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 기능성 식품 등이 있다. 추가로, 본원 발명에서 식품에는 특수영양식품(예, 조제유류, 영,유아식 등), 식육가공품, 어육제품, 두부류, 묵류, 면류(예, 라면류, 국수류 등), 빵류, 건강보조식품, 조미식품(예, 간장, 된장, 고추장, 혼합장 등), 소스류, 과자류(예, 스넥류), 캔디류, 쵸코렛류, 껌류, 아이스크림류, 유가공품(예, 발효유, 치즈 등), 기타 가공식품, 김치, 절임식품(각종 김치류, 장아찌 등), 음료(예, 과실 음료, 채소류 음료, 두유류, 발효음료류 등), 천연조미료(예, 라면 스프 등)를 포함하나 이에 한정되지 않는다. 상기 식품, 음료 또는 식품첨가제는 통상의 제조방법으로 제조될 수 있다.The health food composition according to the present invention includes, for example, various foods, beverages, gum, tea, vitamin complexes, functional foods, and the like. In addition, in the present invention, food includes special nutritional foods (eg, formula milk, infant food, etc.), processed meat products, fish meat products, tofu, jelly products, noodles (eg, ramen, noodles, etc.), breads, health supplements, seasonings Food (eg soy sauce, soybean paste, red pepper paste, mixed soy sauce, etc.), sauces, sweets (eg snacks), candy, chocolate, gum, ice cream, dairy products (eg fermented milk, cheese, etc.), other processed foods, kimchi, Pickled foods (various kimchi, pickles, etc.), beverages (eg fruit drinks, vegetable drinks, soy milk, fermented drinks, etc.), natural seasonings (eg ramen soup, etc.) are included, but not limited thereto. The food, beverage or food additive may be prepared by a conventional manufacturing method.
나아가 본 발명은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 충진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있으며, 상기 성분은 독립적으로 또는 조합하여 사용할 수 있다Furthermore, the present invention provides various nutrients, vitamins, minerals (electrolytes), synthetic flavoring agents and flavoring agents such as natural flavoring agents, coloring agents and fillers (cheese, chocolate, etc.), pectic acid and its salts, alginic acid and its salts, organic acids, It may contain a protective colloidal thickener, a pH adjuster, a stabilizer, a preservative, glycerin, alcohol, a carbonation agent used in carbonated beverages, etc., and the components may be used independently or in combination
또한, 건강식품 조성물에는 식품학적으로 허용 가능한 식품 보조 첨가제를 포함할수 있으며, 기능성 식품의 제조에 통상적으로 사용되는 적절한 담체, 부형제 및 희석제를 더욱 포함할 수 있다In addition, the health food composition may include food pharmaceutically acceptable food supplement additives, and may further include suitable carriers, excipients and diluents commonly used in the manufacture of functional foods.
건강식품 조성물은 다양한 형태로 제형이 가능하므로 그 형태는 특별히 제한되지 않는다. 바람직하게 건강식품 조성물은 과립, 정제, 분말, 환, 캡슐 중에서 선택된 어느 하나의 제형으로 형성될 수 있다. 이러한 과립, 정제, 분말, 환, 캡슐 제형을 갖는 건강식품 조성물은 휴대가 간편하고 언제 어디서나 수시로 섭취하기가 용이하다.Since the health food composition can be formulated in various forms, the form is not particularly limited. Preferably, the health food composition may be formed in any one formulation selected from granules, tablets, powders, pills, and capsules. The health food composition having such granules, tablets, powders, pills, and capsules is easy to carry and easily ingested anytime, anywhere.
바람직하게 본 발명의 누에콜라겐 건강식품 조성물은 분말형태로 구비되어 분말 그대로 섭취할 수 있으며, 냉수 또는 온수 또는 우유 등에 첨가하여 차(tea)로 섭취할 수 있다.Preferably, the silkworm collagen health food composition of the present invention is provided in powder form and can be consumed as it is, and can be consumed as tea by adding it to cold water, hot water, or milk.
한편, 본 발명의 다른 예에 따른 누에콜라겐 건강식품 조성물은 효소처리누에분말, 마린콜라겐, 비타민 C, 첨가물을 함유할 수 있다. 가령, 누에콜라겐 건강식품 조성물은 효소처리누에분말 20 내지 50 중량%, 마린콜라겐 5 내지 40중량%, 비타민C 1 내지 10중량%, 첨가물 30 내지 60중량%를 함유할 수 있다. On the other hand, the silkworm collagen health food composition according to another example of the present invention may contain enzyme-treated silkworm powder, marine collagen, vitamin C, and additives. For example, the silkworm collagen health food composition may contain 20 to 50% by weight of enzyme-treated silkworm powder, 5 to 40% by weight of marine collagen, 1 to 10% by weight of vitamin C, and 30 to 60% by weight of additives.
비타민 C는 콜라겐의 생합성 전구체인 물질로서, 섭취시 몸 자체의 콜라겐 생합성을 위한 물질로 사용된다. Vitamin C is a substance that is a biosynthesis precursor of collagen, and is used as a substance for the body's own collagen biosynthesis when ingested.
첨가물은 누에콜라겐 건강식품 조성물의 기능성을 더하기 위한 것으로서, 참반디 추출물을 이용할 수 있다. The additive is to add the functionality of the silkworm collagen health food composition, and a firefly extract can be used.
참반디(Sanicula chinensis)는 산형과에 속하는 다년생초로서, 숲 속에서 자란다. 참반디는 연할 때 나물로 하고 뿌리줄기는 이뇨제 및 해열제로도 사용된다.Firefly ( Sanicula chinensis ) is a perennial plant belonging to the umbel family, and grows in the forest. Cham firefly is used as an herb when tender, and the rhizome is also used as a diuretic and antipyretic.
참바디 추출물은 참반디의 잎으로부터 추출할 수 있다. 추출의 일 예로 참반디의 잎에 추출용매를 중량비로 2 내지 20배를 가하여 혼합한 후 10 내지 150℃에서 1 내지 48시간 동안 열수추출, 냉침추출 또는 온침추출하여 추출할 수 있다. Charm body extract may be extracted from the leaves of Charm firefly. As an example of extraction, 2 to 20 times the weight ratio of the extraction solvent is added to the leaves of firefly and mixed, and then extracted by hot water extraction, cold chim extraction or hot chim extraction at 10 to 150° C. for 1 to 48 hours.
추출용매로 물, 탄소수 1 내지 4의 저급 알코올, 다가 알코올 또는 이들의 혼합물로부터 선택된 적어도 어느 하나를 이용할 수 있다. 탄소수 1 내지 4의 저급 알코올로 메탄올, 에탄올 등을 이용할 수 있고, 다가 알코올로 부틸렌글리콜 및 프로필렌글리콜, 펜틸렌글리콜 등을 이용할 수 있다. 그리고 혼합물로는 물 및 저급 알코올의 혼합물, 물 및 다가 알코올의 혼합물, 저급 알코올 및 다가 알코올의 혼합물, 또는 물 및 저급알코올 및 다가알코올의 혼합물을 이용할 수 있다.As the extraction solvent, at least one selected from water, a lower alcohol having 1 to 4 carbon atoms, a polyhydric alcohol, or a mixture thereof may be used. Methanol, ethanol, etc. can be used as a C1-C4 lower alcohol, and butylene glycol, propylene glycol, pentylene glycol, etc. can be used as a polyhydric alcohol. And as the mixture, a mixture of water and a lower alcohol, a mixture of water and a polyhydric alcohol, a mixture of a lower alcohol and a polyhydric alcohol, or a mixture of water and a lower alcohol and a polyhydric alcohol may be used.
추출 후 여과 및 감압농축한 후 동결건조, 분무건조 방식 등을 통해 분말 형태의 참반디 추출물을 얻을 수 있다. 동결건조 일 예로 -50 내지 -40℃의 온도에서 10 내지 20시간 급속동결시킨 다음, 0.1 내지 0.5torr의 진공도를 가진 동결건조기에서 약 -40℃에서 48시간 동안 건조시킨 다음 100 내지 300매쉬 입도 크기로 분쇄한다. After extraction, filtration and concentration under reduced pressure, a powder form of firefly extract can be obtained through freeze-drying, spray-drying, etc. Freeze-drying For example, rapidly frozen at a temperature of -50 to -40 ° C for 10 to 20 hours, then dried at about -40 ° C for 48 hours in a freeze dryer with a vacuum degree of 0.1 to 0.5 torr, and then 100 to 300 mesh particle size crushed with
그리고 첨가물로 참반디 추출물 외에도 무수결정포도당, 결정셀루로오스, L-아르기닌, 비타민/미네랄프리믹스 구성되는 군으로부터 선택된 어느 하나 이상을 더 포함할 수 있으며, 또한 향미제, 풍미제, 착색제를 더 포함할 수 있다. And as an additive, in addition to the firefly extract, it may further include any one or more selected from the group consisting of anhydrous crystalline glucose, crystalline cellulose, L-arginine, and vitamins/mineral premix, and may further include flavoring agents, flavoring agents, and coloring agents. can
이하, 본 발명의 바람직한 실시 예에 따른 누에콜라겐 건강식품 조성물의 제조방법에 대해 각 단계별로 설명한다.Hereinafter, a method for producing a silkworm collagen health food composition according to a preferred embodiment of the present invention will be described in each step.
1. 효소처리누에분말을 수득하는 제 1단계와1. The first step of obtaining the enzyme-treated silkworm powder and
먼저, 누에분말을 효소처리하여 효소처리누에분말을 수득한다. First, the silkworm powder is treated with an enzyme to obtain an enzyme-treated silkworm powder.
효소처리누에분말을 수득하는 과정은 a)누에를 동결건조시켜 100 내지 300메쉬 입도 크기의 상기 누에분말을 얻는 단계와, b)상기 누에분말을 물에 현탁하여 누에현탁액을 제조하는 단계, c)상기 누에현탁액에 단백질 분해효소를 첨가하여 40 내지 70℃에서 1 내지 2일간 가수분해시켜 가수분해물을 수득하는 단계, d)상기 가수분해물을 분무건조시켜 효소처리누에분말을 수득하는 단계로 이루어질 수 있다. The process of obtaining the enzyme-treated silkworm powder is a) freeze-drying the silkworm to obtain the silkworm powder having a particle size of 100 to 300 mesh, b) suspending the silkworm powder in water to prepare a silkworm suspension, c) It may consist of a step of adding a proteolytic enzyme to the silkworm suspension and hydrolyzing it at 40 to 70° C. for 1 to 2 days to obtain a hydrolyzate, d) spray-drying the hydrolyzate to obtain an enzyme-treated silkworm powder. .
누에로 식용가능한 종은 모두 사용이 가능하다. 누에로 꾸지뽕잎을 먹고 자란 누에를 사용하는 것이 바람직하다. 누에분말을 얻기 위해 건조방식으로는 어떠한 것을 적용하여도 무관하나, 누에의 성분변화를 최소화하기 위해 동결건조방식을 적용하는 것이 바람직하다.Any edible species of silkworm can be used. It is preferable to use silkworms grown by eating Cuji mulberry leaves as silkworms. In order to obtain silkworm powder, any drying method may be applied, but it is preferable to apply a freeze-drying method to minimize changes in the composition of silkworms.
일 예로 살아있는 5령3일의 누에를 영하 40 내지 50℃ 조건에서 8 내지 16시간 동안 급속동결시킨 뒤, 영하 70℃의 진공챔버에서 다시 2 내지 10시간 동안 동결시켜 건조시킨다. 이후 분쇄기로 분쇄하여 100 내지 300입도 크기의 누에분말을 수득할 수 있다. For example, live silkworms of 3 days of age 5 are rapidly frozen at -40 to 50 ° C. for 8 to 16 hours, and then dried by freezing again in a vacuum chamber at -70 ° C. for 2 to 10 hours. Thereafter, it is pulverized with a grinder to obtain silkworm powder having a particle size of 100 to 300.
다음으로, 누에분말을 물에 현탁하여 누에현탁액을 제조한다. 물은 누에 분말 1g당 5~20ml를 첨가하는 것이 좋다. 물이 5ml미만으로 첨가될 경우 누에현탁액이 액상형 상태로 이루어지지 않아 효소반응이 제대로 이루어지지 않은 문제가 있으며, 20ml를 초과하여 첨가할 경우에는 수분함량이 많아 효소반응이 잘 이루어지지 않는다.Next, the silkworm powder is suspended in water to prepare a silkworm suspension. It is recommended to add 5~20ml of water per 1g of silkworm powder. When water is added to less than 5 ml, there is a problem that the enzymatic reaction is not performed properly because the silkworm suspension is not made in a liquid state.
또한, 누에현탁액의 pH를 조정하기 위해 수산화나트륨(NaOH)용액 또는 염화수소(HCl)용액을 첨가할 수 있다. 이 경우 누에분말 현탁액의 pH는 5~7로 조정할 수 있다. In addition, sodium hydroxide (NaOH) solution or hydrogen chloride (HCl) solution may be added to adjust the pH of the silkworm suspension. In this case, the pH of the silkworm powder suspension can be adjusted to 5-7.
다음으로, 누에현탁액에 단백질 분해효소를 첨가하여 가수분해물을 수득한다. Next, a hydrolyzate is obtained by adding a proteolytic enzyme to the silkworm suspension.
단백질 분해효소로 브로멜라인(Bromelain), 파파인(Papain), 프로타맥스 (Protamax), 트립신(Trypsin), 프로리테르 FG-F(Proleather FG-f), 플라보자임(Flavourzyme), 프로테아제 A(Protease A), 에이로즈 AP-10(Aroase AP-10), 피스칼레이즈(Pescalase), Protease P, Protease N, Alcalase 2.4L, 피신(Ficin) 및 뉴트레이즈(Neutrase)로 구성되는 군으로부터 선택된 어느 하나 이상을 이용할 수 있다. 바람직하게는 단백질 분해효소로 브로멜라인과 파파인을 함께 이용한다. 브로멜라인과 파파인을 함께 이용할 경우 누에 단백질의 분해효과가 높으며 반응이 빠르다. Proteases Bromelain, Papain, Protamax, Trypsin, Proleather FG-f, Flavozyme, Protease A (Protease A), Aroase AP-10 (Aroase AP-10), Fiscalase (Pescalase), Protease P, Protease N, Alcalase 2.4L, Ficin (Ficin) and selected from the group consisting of Neutrase (Neutrace) Any one or more may be used. Preferably, bromelain and papain are used together as proteolytic enzymes. When bromelain and papain are used together, the decomposition effect of silkworm protein is high and the reaction is fast.
단백질 분해효소는 누에현탁에 100중량부에 대하여 0.1 내지 2중량부를 첨가할 수 있다. 가령, 누에현탁액 100중량부에 대하여 브로멜라인 0.5중량부와, 파파인 1.0중량부를 첨가할 수 있다. The protease may be added in an amount of 0.1 to 2 parts by weight based on 100 parts by weight of the silkworm suspension. For example, 0.5 parts by weight of bromelain and 1.0 parts by weight of papain may be added based on 100 parts by weight of the silkworm suspension.
누에현탁액에 단백질 분해효소를 첨가한 다음 40 내지 70℃에서 1 내지 2일간 교반하여 누에분말을 가수분해시킨다. 이와 같이 수득한 가수분해물은 90℃에서 30분동안 가열하여 불활화시킨다. After adding a protease to the silkworm suspension, it is stirred at 40 to 70° C. for 1 to 2 days to hydrolyze the silkworm powder. The hydrolyzate thus obtained was inactivated by heating at 90 DEG C for 30 minutes.
다음으로, 가수분해물을 건조시켜 효소처리누에분말을 수득한다. 건조방법으로 스프레이 건조법을 이용할 수 있다. 스프레이 건조(spray drying)는 액체를 열풍 속에 분무시켜 건조시키는 방법으로, 스프레이건조기에 가수분해물을 분무시켜 200 내지 400메쉬 입도크기의 효소처리누에분말을 수득한다. Next, the hydrolyzate is dried to obtain an enzyme-treated silkworm powder. As a drying method, a spray drying method may be used. Spray drying is a method of drying a liquid by spraying it in hot air. By spraying a hydrolyzate in a spray dryer, an enzyme-treated silkworm powder having a particle size of 200 to 400 mesh is obtained.
2. 마린콜라겐을 준비하는 제 2단계2. The second step to prepare marine collagen
마린콜라겐은 어류로부터 추출된 콜라겐이다. 이러한 마린콜라겐으로 상업화된 분말 제품을 이용할 수 있다.Marine collagen is collagen extracted from fish. A powder product commercialized as such marine collagen is available.
또한, 마린콜라겐은 어류로부터 직접 추출하여 이용할 수 있다. 바람직하게 어류의 부산물의 어피로부터 마린콜라겐을 추출한다.In addition, marine collagen can be directly extracted from fish and used. Preferably, marine collagen is extracted from the fish skin of by-products of fish.
어피는 어류의 껍질로서, 넙치나 우럭, 농어, 참돔, 연어 등의 껍질을 이용할 수 있다. The fish skin is a shell of fish, and shells of halibut, eel, sea bass, red sea bream, salmon, etc. can be used.
마린 콜라겐 추출을 위해 어피 분말에 수산화나트륨 용액을 가하여 비콜라겐성 단백질이 제거된 알칼리잔사를 수득하는 단계와, 상기 알칼리잔사에 초산용액을 가하여 교반한 후 원심분리기로 상등액을 분리하여 산가용화콜라겐을 추출하는 단계와, 상기 산가용화 콜라겐에 펩신을 가하여 교반한 후 원심분리기로 상등액을 분리한 다음 염화나트륨 용액을 가하여 침전시킨 침전물을 증류수로 투석하여 펩신 가용화 콜라겐을 추출하는 단계와, 상기 펩신 가용화 콜라겐을 정제하는 정제단계를 수행할 수 있다.For marine collagen extraction, a sodium hydroxide solution is added to the fish skin powder to obtain an alkali residue from which non-collagenous proteins are removed, and an acetic acid solution is added to the alkali residue and stirred, and then the supernatant is separated by a centrifuge to obtain acid-solubilized collagen. Extracting, adding pepsin to the acid-solubilized collagen and stirring, separating the supernatant with a centrifuge, and dialyzing the precipitate precipitated by adding sodium chloride solution to distilled water to extract pepsin-solubilized collagen; A purification step of refining may be performed.
먼저, 어피는 세척하여 건조시킨 다음 50 내지 150메쉬 입도 크기로 분쇄하여 어피 분말을 준비한다. 건조 전 어피에 붙은 비늘을 제거하는 전처리과정을 거칠 수 있다. 이를 위해 세척한 어피를 0.1M 수산화나트륨 용액에 혼합하여 6 내지 12시간 동안 교반한다. 수산화나트륨 용액과 교반하게 되면 생선종류에 따라 다소 차이가 있으나 80 내지 90%의 비늘이 용이하게 제거된다. First, the fish skin is washed and dried, and then pulverized to a particle size of 50 to 150 mesh to prepare a fish skin powder. You can go through a pre-treatment process to remove the scales attached to the fish skin before drying. For this purpose, the washed fish is mixed with 0.1M sodium hydroxide solution and stirred for 6 to 12 hours. When stirred with sodium hydroxide solution, there is a slight difference depending on the type of fish, but 80 to 90% of scales are easily removed.
어피 분말과 수산화나트륨 용액을 1:5 내지 10의 중량비로 혼합한 다음 실온(20~25℃)에서 12 내지 24시간 동안 교반한 후 원심분리기를 이용하여 비콜라겐성 단백질이 제거된 알칼리잔사를 수득할 수 있다.After mixing fisheye powder and sodium hydroxide solution in a weight ratio of 1:5 to 10, stirring at room temperature (20-25°C) for 12 to 24 hours, and then using a centrifuge to obtain alkali residues from which non-collagenous proteins have been removed can do.
그리고 알칼리잔사를 증류수로 세척한 다음 초산용액을 가해 콜라겐을 추출한다. 알칼리잔사와 초산용액을 1:5 내지 10의 중량비로 혼합한 다음 실온(20~25℃)에서 12 내지 24시간 동안 교반한 후 원심분리기를 이용하여 상등액을 분리하여 산 가용화 콜라겐을 수득한다.Then, after washing the alkali residue with distilled water, acetic acid solution is added to extract collagen. The alkali residue and the acetic acid solution are mixed in a weight ratio of 1:5 to 10, stirred at room temperature (20-25° C.) for 12 to 24 hours, and then the supernatant is separated using a centrifuge to obtain acid-solubilized collagen.
그리고 산 가용화 콜라겐에 펩신을 가하여 10 내지 20시간 동안 교반한 후 원심분리기로 상등액을 분리한 다음 2M의 염화나트륨 용액을 가하여 침전시킨 침전물을 증류수로 투석하여 펩신 가용화 콜라겐을 얻을 수 있다.Then, pepsin is added to the acid-solubilized collagen, stirred for 10 to 20 hours, the supernatant is separated by centrifugation, and the precipitate precipitated by adding 2M sodium chloride solution is dialyzed with distilled water to obtain pepsin-solubilized collagen.
그리고 펩신 가용화 콜라겐을 정제하여 마린 콜라겐을 얻기 위해, 펩신가용화 콜라겐을 20mM Na2HPO4에서 투석하여 펩신을 불활성화시킨 다음 요소를 포함한 50mM 초산용액(pH 4.8)에 대해 투석한 후 이온크로마토그래피를 이용하여 분획을 용출시킨다. 가령, 인산셀률로오스(P11, Whatman, Maidstone, UK)를 충진한 컬럼에서 0~600mM NaCl의 linear gradient(60ml/h)로 정제를 진행하고, 230nm에서 용출된 분획을 2.0M NaCl을 포함한 0.5M 초산용액으로 투석하여 회수한 다음 증류수로 투석, 동결건조하여 고순도의 마린콜라겐을 얻을 수 있다. 마린콜라겐은 200 내지 400메쉬 입도 크기의 분말 형태로 이용한다. Then, to obtain marine collagen by purifying pepsin-solubilized collagen, pepsin-solubilized collagen was dialyzed against 20 mM Na2HPO4 to inactivate pepsin, and then dialyzed against a 50mM acetic acid solution (pH 4.8) containing urea, followed by fractionation using ion chromatography. elute For example, in a column filled with cellulose phosphate (P11, Whatman, Maidstone, UK), purification is performed with a linear gradient (60 ml/h) of 0 to 600 mM NaCl, and the fraction eluted at 230 nm is 0.5 containing 2.0 M NaCl. It is recovered by dialysis with M acetic acid solution, then dialyzed with distilled water and freeze-dried to obtain high-purity marine collagen. Marine collagen is used in powder form with a particle size of 200 to 400 mesh.
3. 효소처리누에분말과 마린콜라겐을 혼합하는 제 3단계3. 3rd step of mixing enzyme-treated silkworm powder and marine collagen
효소처리누에분말과 마린콜라겐이 준비되면, 효소처리누에분말 1 내지 90중량%, 마린콜라겐 1 내지 90중량%의 비율로 혼합하여 최종적으로 본 발명의 누에콜라겐 건강식품 조성물을 제조할 수 있다. When the enzyme-treated silkworm powder and marine collagen are prepared, the enzyme-treated silkworm powder is mixed in a ratio of 1 to 90% by weight and 1 to 90% by weight of marine collagen to finally prepare the silkworm collagen health food composition of the present invention.
또한, 효소처리누에분말, 마린콜라겐 외에 비타민 C, 첨가물을 더 혼합하여 본 발명의 누에콜라겐 건강식품 조성물을 제조할 수 있다. 이 경우 효소처리누에분말 20 내지 50 중량%, 마린콜라겐 5 내지 40중량%, 비타민C 1 내지 10중량%, 첨가물 30 내지 60중량%의 비율로 혼합할 수 있다. In addition, the enzyme-treated silkworm powder and marine collagen may be further mixed with vitamin C and additives to prepare the silkworm collagen health food composition of the present invention. In this case, 20 to 50% by weight of the enzyme-treated silkworm powder, 5 to 40% by weight of marine collagen, 1 to 10% by weight of vitamin C, and 30 to 60% by weight of additives may be mixed.
이하, 본 발명을 하기 실시예에 의해 상세히 설명한다. 단, 하기 실시 예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시 예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of Examples. However, the following examples are only illustrative of the present invention, and the content of the present invention is not limited to the following examples.
<가수분해 효소선정><Selection of hydrolytic enzyme>
누에분말은 상업화된 제품을 시중에서 구입하여 준비하였다. 누에분말 100g에 증류수 1000㎖를 넣고 실온에서 30분 동안 혼합하여 누에현탁액을 제조하였다.Silkworm powder was prepared by purchasing commercially available products. 1000 ml of distilled water was added to 100 g of silkworm powder and mixed at room temperature for 30 minutes to prepare a silkworm suspension.
누에현탁액 10ml에 브로멜라인(Bromelain), 파파인(Papain), 프로타맥스 (Protamax), 트립신(Trypsin)을 각각 0.01g 씩 첨가하여 총 4개의 시료를 준비한 후, 쉐이킹 인큐베이터(shaking incubator)를 이용하여 50℃에서 120시간 동안 반응시킨 후 SDS-PAGE(sodium dodecyl sulfate polyacrylamide gel electrophoresis)를 수행하였다.After preparing a total of 4 samples by adding 0.01 g each of Bromelain, Papain, Protamax, and Trypsin to 10 ml of silkworm suspension, use a shaking incubator and reacted at 50°C for 120 hours, followed by SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis).
단백질 마커(protein marker)는 시그마사(Sigma, 미국)에서 구입하여 샘플 버퍼(sample buffer; 60mM Tris-HCl, 25% glycerol, 2% SDS, 14.4mM 2-mercaptoethanol,0.1% bromophenol blue, 10mL distilled water)에 용해시켰다. 각 시료와 샘플 버퍼를 동량 첨가한 후 100℃의 물에서 5분간 가열하여 단백질의 완전한 변성을 유도한 후 전기영동을 실시하였다(MiniProtean, BIO-RAD Laboratories, Inc. USA.). 전기영동용 완충용액은 0.1%(w/v) SDS를 포함하는 0.025M-Trisbase-0.192 M Glycine(pH8.3) 용액을 사용하였으며 이렇게 얻어진 겔의 염색은 쿠마시 블루 R-250 용액(Coomasie blue R-250; 1.0g Coomassie blue R-250, 450mL methanol, 450mL H2O, 100mL glacial acetic acid)을 사용하여 상온에서 2시간 가량 흔들며 수행하였다. 탈색은 탈색시약(100mL methanol, 100mL glacialacetic acid, 800mL H2O)을 겔이 살짝 잠길 만큼 부어 30분간 두 번에 걸쳐 시약을 교환하면서 흔들며 수행하였고 추가로 겔이 완전히 잠기도록 하여 18시간 가량 흔들며 탈색하였다. 이때 얻어진 겔상에 염색된 밴드는 단백질 마커와 비교하여 도 1에 나타내었다. Protein markers were purchased from Sigma (USA) and sample buffer (60mM Tris-HCl, 25% glycerol, 2% SDS, 14.4mM 2-mercaptoethanol, 0.1% bromophenol blue, 10mL distilled water) ) was dissolved in After adding the same amount of each sample and sample buffer, it was heated in water at 100° C. for 5 minutes to induce complete denaturation of the protein, followed by electrophoresis (MiniProtean, BIO-RAD Laboratories, Inc. USA.). As the buffer solution for electrophoresis, 0.025M-Trisbase-0.192 M Glycine (pH8.3) solution containing 0.1% (w/v) SDS was used, and the resulting gel was stained with Coomasie blue R-250 solution (Coomasie blue). R-250; 1.0g Coomassie blue R-250, 450mL methanol, 450mL H2O, 100mL glacial acetic acid) was used at room temperature for 2 hours with shaking. Decolorization was carried out by pouring a decolorization reagent (100mL methanol, 100mL glacialacetic acid, 800mL H2O) to lightly submerge the gel and shaking while exchanging the reagents twice for 30 minutes. The bands stained on the gel obtained at this time were compared with the protein markers and are shown in FIG. 1 .
도 1을 참조하면, 프로타맥스나 트립신에 비해 브로멜라인과 파파인을 사용시 가수분해 효과가 더 우수한 것으로 확인되었다. Referring to FIG. 1 , it was confirmed that the hydrolysis effect was more excellent when using bromelain and papain compared to protamax or trypsin.
<누에콜라겐 건강식품 조성물의 제조><Production of silkworm collagen health food composition>
단백질 가수분해 효소로서 브로멜라인과 파파인을 이용하여 누에콜라겐 건강식품 조성물을 제조하였다. A silkworm collagen health food composition was prepared using bromelain and papain as proteolytic enzymes.
(실시예 1)(Example 1)
누에분말과 마린콜라겐 분말은 상업화된 제품을 시중에서 구입하여 준비하였다. 누에분말 100g에 증류수 1000㎖를 넣고 실온에서 30분 동안 혼합하여 누에분말을 현탁시켜 누에현탁액을 제조하였다. 누에현탁액 1000g에 브로멜라인(Bromelain) 5g과 파파인(Papain) 10g을 첨가한 후, 쉐이킹 인큐베이터(shanking incubator)를 이용하여 60℃에서 24시간 동안 가수분해하여 가수분해물을 수득하였다.Silkworm powder and marine collagen powder were prepared by purchasing commercially available products. 1000 ml of distilled water was added to 100 g of silkworm powder, mixed at room temperature for 30 minutes, and the silkworm powder was suspended to prepare a silkworm suspension. After adding 5 g of bromelain and 10 g of papain to 1000 g of silkworm suspension, hydrolysis was performed at 60° C. for 24 hours using a shaking incubator to obtain a hydrolyzate.
그 다음 가수분해물을 멸균기에 넣고 90℃에 30분 동안 효소불활화를 시키고, 스프레이건조기를 통해 약 200메쉬의 크기를 갖는 효소처리누에분말을 수득하였다. Then, the hydrolyzate was put into a sterilizer and enzymatically inactivated at 90° C. for 30 minutes, and an enzyme-treated silkworm powder having a size of about 200 mesh was obtained through a spray dryer.
그리고 효소처리누에분말과 마린콜라겐을 7:3의 중량비로 혼합하여 분말형태의 누에콜라겐 건강식품 조성물을 제조하였다.And enzyme-treated silkworm powder and marine collagen were mixed in a weight ratio of 7:3 to prepare a powdered silkworm collagen health food composition.
(실시예 2)(Example 2)
실시예 1에서 사용된 효소처리누에분말과 마린콜라겐에 비타민C, 참반디추출물을 혼합하여 누에콜라겐 건강식품 조성물을 제조하였다. 즉, 효소처리누에분말 40중량%, 마린콜라겐 25중량%, 비타민C 5중량%, 무수결정포도당 20, 참반디 추출물 10중량%의 비율로 혼합하여 누에콜라겐 건강식품 조성물을 제조하였다. The enzyme-treated silkworm powder and marine collagen used in Example 1 were mixed with vitamin C and firefly extract to prepare a silkworm collagen health food composition. That is, by mixing enzyme-treated silkworm powder 40% by weight,
참반디추출물은 참반디 잎에 대하여 추출용매로서 물을 중량비로 8배를 가한 후 90℃에서 6시간 동안 추출한후 여과지 여과한 다음 동결건조시켜 150메쉬 입도 크기의 분말로 수득하였다. Firefly extract was obtained by adding 8 times the weight ratio of water as an extraction solvent to the leaves of Firefly, followed by extraction at 90° C. for 6 hours, filtered through filter paper, and then freeze-dried to obtain a powder having a particle size of 150 mesh.
<시료준비><Sample preparation>
실시 예1의 누에콜라겐 건강식품 조성물에 농도 80% 에틸알코올(ethyl alcohol)을 1:4(w/v)의 비율로 첨가하여 상온에서 24시간 동안 150rpm으로 진탕하였다. 그 후 3,000 rpm 에서 20분간 원심 분리시켜 침전물을 제거하였다. 이를 다시 syringe filter를 이용하여 부유성분을 걸러내어 이하의 실험에 사용할 시료를 준비하였다. To the silkworm collagen health food composition of Example 1, 80% ethyl alcohol was added in a ratio of 1:4 (w/v) and shaken at 150rpm for 24 hours at room temperature. Thereafter, the precipitate was removed by centrifugation at 3,000 rpm for 20 minutes. This was again filtered by using a syringe filter to prepare a sample to be used for the following experiments.
<세포독성실험><Cytotoxicity test>
인슐린 분비능 평가 실험에 사용하는 RIN-m5F 세포에 대하여 세포독성 확인 실험을 진행하였다. A cytotoxicity test was performed on the RIN-m5F cells used in the insulin secretory ability evaluation experiment.
RIN-m5F 세포주는 American type culture collection (ATCC, USA)으로부터 분양 받아 10% fetal bovine serum (FBS)가 함유된 RPMI-1640 배지를 이용하여 37℃, 5% CO2 조건에서 배양하였다. 그 다음 RIN-m5F 세포주를 2 x 104 cells/well의 농도로 96 well culture plate에 분주하고 24시간 배양 후 시료를 10% fetal bovine serum (FBS)가 함유된 RPMI-1640 배지를 이용하여 평가 농도로 희석하여 시험물질을 준비하였다.The RIN-m5F cell line was purchased from the American type culture collection (ATCC, USA) and cultured at 37° C. and 5% CO 2 condition using RPMI-1640 medium containing 10% fetal bovine serum (FBS). Then, the RIN-m5F cell line was dispensed in a 96-well culture plate at a concentration of 2 x 10 4 cells/well, and the sample was cultured for 24 hours using RPMI-1640 medium containing 10% fetal bovine serum (FBS) to evaluate the concentration. The test substance was prepared by diluting it with
시험물질을 24시간 배양하고 MTT solution을 최종 농도가 0.5mg/mL이 되도록 첨가한 후 4시간 동안 반응시켰다. 배지를 제거한 후 100μL의 DMSO를 이용하여 cell lysis 후 microplate reader (Molecular device)를 이용하여 540㎚에서 triplicate (3 wells)로 흡광도를 측정하였다. 도 2에 실험결과를 나타내었다.The test substance was incubated for 24 hours, and MTT solution was added so that the final concentration was 0.5 mg/mL, and then reacted for 4 hours. After removing the medium, cell lysis was performed using 100 μL of DMSO, and absorbance was measured with triplicate (3 wells) at 540 nm using a microplate reader (Molecular device). 2 shows the experimental results.
도 2를 참조하면, 농도에 따른 세포생존율을 평가한 결과 10, 5, 2.5, 1.25, 0.63, 0.31, 0.16, 0.08, 0.04, 0.02 및 0.01%에서 4.7±1.9%, 8.5±44%, 10.2±4.3%0, 72.4±7.9%, 90.5±3.2%, 98.6±2.4%, 98.6±6.5%, 105.9±7.2%, 91.8±3.0%, 97.7±7.1% 및 110.0±4.9%로 확인되어 약 0.63% 농도에서부터 세포독성이 확인되지 않았다. 2, as a result of evaluating cell viability according to concentration, 4.7±1.9%, 8.5±44%, 10.2± at 10, 5, 2.5, 1.25, 0.63, 0.31, 0.16, 0.08, 0.04, 0.02 and 0.01% 4.3% 0, 72.4±7.9%, 90.5±3.2%, 98.6±2.4%, 98.6±6.5%, 105.9±7.2%, 91.8±3.0%, 97.7±7.1%, and 110.0±4.9% were identified as about 0.63% concentration No cytotoxicity was observed.
<항당뇨 실험><Anti-diabetes experiment>
본 발명의 누에콜라겐 조성물의 항당뇨성 실험을 위해 α-glucosidase의 저해 활성 및 인슐린 분비능에 대한 in-vitro 항당뇨 효능을 평가하고자 실험하였다.For the antidiabetic test of the silkworm collagen composition of the present invention, an experiment was conducted to evaluate the in-vitro antidiabetic effect on the inhibitory activity of α-glucosidase and the insulin secretion ability.
1)α-glucosidase의 저해 활성 평가 실험1) α-glucosidase inhibitory activity evaluation experiment
항당뇨 실험을 위해α-glucosidase의 저해 활성 평가를 하고자 하기와 같은 실험을 진행하였다. The following experiment was conducted to evaluate the inhibitory activity of α-glucosidase for the antidiabetic experiment.
시료를 50mM potassium phosphate buffer(pH6.8)를 이용하여 농도 25, 12.5, 6.25, 3.125, 1.563, 0.781, 0.391, 0.195, 0.098, 0.049, 0.024 및 0.0%로 시험물질을 준비하였다. 각 농도별 시험물질 50μL에 2.5mM p-nitrophenyl α-D-glucopyranoside(pNPG) 100μL 를 첨가하고 α-glucosidase(시그마, USA) 50μL를 첨가 후 37℃에서 반응시키면서 pNPG로부터 유리되어 나오는 반응 생성물인 p-nitrophenol을 405nm에서 10분간 1분 간격으로 흡광도를 측정하여 나온 반응속도를 통하여 α-glucosidase 활성의 억제정도를 triplicate(3 wells)로 측정하였다. 양성대조물질로 Acarbose를 사용하였으며, acarbose(시그마,USA)를 50mM potassium phosphate buffer(pH6.8)에 처리하여 농도별로 평가하였다. 도 3에 실험결과를 나타내었다.Samples were prepared at concentrations of 25, 12.5, 6.25, 3.125, 1.563, 0.781, 0.391, 0.195, 0.098, 0.049, 0.024 and 0.0% using 50 mM potassium phosphate buffer (pH6.8). To 50 μL of each concentration test substance, 100 μL of 2.5 mM p-nitrophenyl α-D-glucopyranoside (pNPG) was added, and 50 μL of α-glucosidase (Sigma, USA) was added and reacted at 37 ° C. The degree of inhibition of α-glucosidase activity was measured with triplicate (3 wells) through the reaction rate obtained by measuring the absorbance of -nitrophenol at 405 nm for 10 minutes at 1 minute intervals. Acarbose was used as a positive control material, and acarbose (Sigma, USA) was treated in 50 mM potassium phosphate buffer (pH6.8) to evaluate each concentration. 3 shows the experimental results.
도 3을 참조하면, 본 발명의 실험군의 농도에 따른 α-glucosidase 활성억제능을 측정한 결과 25, 12.5, 6.25, 3.125, 1.563, 0.781, 0.391, 0.195, 0.098, 0.049, 0.024 및 0.0%에서 각각 96.4±0.3%, 93.4±1.4%, 91.9±1.1%, 79.4±0.9%, 68.9±1.8%, 55.6±1.6%, 41.2±1.3%, 29.6±0.9%, 21.7±1.7%, 19.1±1.2%, 16.5±0.9% 및 0.0±0.0%로 확인되어 α-glucosidase를 50% 저해시키는 농도가 약 0.6%로 확인되었다. 3, as a result of measuring the α-glucosidase activity inhibitory ability according to the concentration of the experimental group of the present invention, 25, 12.5, 6.25, 3.125, 1.563, 0.781, 0.391, 0.195, 0.098, 0.049, 0.024 and 0.0% were respectively 96.4. ±0.3%, 93.4±1.4%, 91.9±1.1%, 79.4±0.9%, 68.9±1.8%, 55.6±1.6%, 41.2±1.3%, 29.6±0.9%, 21.7±1.7%, 19.1±1.2%, 16.5 It was confirmed as ±0.9% and 0.0 ±0.0%, and the concentration that inhibited α-glucosidase by 50% was confirmed to be about 0.6%.
2) 인슐린 분비능 평가실험2) Insulin secretion ability evaluation experiment
쥐 췌장 세포종에서 유래된 인슐린종(insulinoma) 세포주로서 항당뇨의 인슐린 분비능 평가 연구에서 널리 사용되고 있는 시험계로서 세포주에 대한 자료가 축적되어 있는 RIN-m5F 세포주를 이용하여 인슐린 분비능 평가실험을 진행하였다.As an insulinoma cell line derived from a mouse pancreatic cell tumor, an insulin secretory ability evaluation experiment was conducted using the RIN-m5F cell line, a test system widely used in studies to evaluate the insulin secretion ability of antidiabetic cells.
RIN-m5F 세포주는 American type culture collection (ATCC, USA)으로부터 분양 받아 10% fetal bovine serum (FBS)가 함유된 RPMI-1640 배지를 이용하여 37℃, 5% CO2 조건에서 배양하였다. RINm5F 세포주를 5 x 105 cells/well의 농도로 48 well culture plate에 분주하고 24시간 배양하였다. 각 well의 세포들을 115mM NaCl, 4.7 mM KCl, 1.28 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 24 mM NaHCO3, 10 mM HEPES-free acid, 1 g/L bovine serumalbumin, 그리고 1.1 mM D-glucose로 구성된 Kreb’s Ringer Buffer(pH 7.4)으로 5분씩 3번 반복 세척하였다. 5.6mM D-glucose 가 포함된 Kreb’s Ringer Buffer에 시료의 농도를 달리하여 500μL씩 세포가 있는 각 well에 넣고 1시간 동안 반응시켰다. 반응액인 상층액을 취하여 insulin을 분석하였다. Insulin 농도는 Morinaga UltraSensitive MouseInsulin ELISA Kit(Morinaga Institute of Biological Science, Japan)을 이용하여 triplicate(3wells)로 측정하였다. 양성 대조군으로 glibenclamide를 5μg/mL 단일의 농도로 처리하여 동일하게 평가하였다. 도 4 내지 도 5에 실험결과를 나타내었다.The RIN-m5F cell line was purchased from the American type culture collection (ATCC, USA) and cultured at 37° C. and 5% CO 2 condition using RPMI-1640 medium containing 10% fetal bovine serum (FBS). The RINm5F cell line was aliquoted into a 48 well culture plate at a concentration of 5 x 10 5 cells/well and cultured for 24 hours. Cells in each well were treated with 115 mM NaCl, 4.7 mM KCl, 1.28 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 24 mM NaHCO3, 10 mM HEPES-free acid, 1 g/L bovine serumalbumin, and 1.1 mM D-glucose. Washing was repeated 3 times for 5 minutes each with Kreb's Ringer Buffer (pH 7.4). In Kreb's Ringer Buffer containing 5.6mM D-glucose, 500 μL of each sample was placed in each well with cells and reacted for 1 hour. The reaction solution, the supernatant, was taken and insulin was analyzed. Insulin concentration was measured in triplicate (3 wells) using the Morinaga UltraSensitive Mouse Insulin ELISA Kit (Morinaga Institute of Biological Science, Japan). As a positive control, glibenclamide was treated at a single concentration of 5 μg/mL and the same evaluation was performed. 4 to 5 show the experimental results.
도 4 내지 도 5를 참조하면, 실험군에서 세포 독성이 없는 농도에서 인슐린 분비능을 평가하였다. 평가 결과 vehicle 군의 경우 3.08±0.10 ng/mL로 측정되었고, 양성 대조군인 glibenclamide 5ug/mL 의 경우 4.36±0.17 ng/mL로 vehicle 군 대비 유의적인 수치상승이 확인되었다. 실험군은 0.04, 0.08, 0.15, 0.3 및 0.6%에서 각각 4.22±0.10 ng/mL, 4.62±0.26 ng/mL, 5.05±0.09 ng/mL, 5.41±015 ng/mL 및 5.62±0.45ng/mL로 확인되어 vehicle 군 대비 모든 농도에서 유의적인 수치상승이 확인되었다.4 to 5 , the insulin secretion ability was evaluated at a concentration without cytotoxicity in the experimental group. As a result of the evaluation, the vehicle group was measured to be 3.08±0.10 ng/mL, and the positive control, glibenclamide 5ug/mL, was 4.36±0.17 ng/mL, a significant increase compared to the vehicle group. The experimental group was 4.22±0.10 ng/mL, 4.62±0.26 ng/mL, 5.05±0.09 ng/mL, 5.41±015 ng/mL and 5.62±0.45 ng/mL at 0.04, 0.08, 0.15, 0.3 and 0.6%, respectively. As a result, a significant increase was confirmed at all concentrations compared to the vehicle group.
상술한 항당뇨 실험결과를 종합해 볼 때, 본 발명의 누에콜라겐 건강식품 조성물은 특정 농도에서 α-glucosidase 의 저해 효과와 함께 인슐린 분비를 증가시키는 것으로 확인되었다.When the above-mentioned antidiabetic experimental results are taken together, it was confirmed that the silkworm collagen health food composition of the present invention increased insulin secretion with the inhibitory effect of α-glucosidase at a specific concentration.
<수용성 실험><Water solubility test>
실시예 2에서 제조된 누에콜라겐 건강식품 조성물은 도 6에 나타낸 바와 같이 녹색의 분말형태로 구비된다. 분말상의 누에콜라겐 건강식품 조성물이 물에 잘 녹는지 확인하기 위하여 하기와 같은 수용성 실험을 실시하였다. The silkworm collagen health food composition prepared in Example 2 is provided in the form of green powder as shown in FIG. 6 . In order to check whether the powdered silkworm collagen health food composition dissolves well in water, the following water solubility test was performed.
물 10ml에 누에콜라겐 건강식품 조성물을 각각 0.1g, 0.5g, 1g, 15g씩 투입한 총 4개의 시험관을 준비했다. 각 시험관의 내용물을 유리막대로 잘 저어준 후 육안으로 관찰된 모습을 도 7에 나타내었다. A total of 4 test tubes were prepared in which 0.1 g, 0.5 g, 1 g, and 15 g of the silkworm collagen health food composition was added to 10 ml of water, respectively. After stirring the contents of each test tube well with a glass rod, the appearance observed with the naked eye is shown in FIG. 7 .
본 발명의 누에콜라겐 건강식품 조성물은 분말형태로 이루어져 있으며, 비교적 물에 잘 녹는다는 것을 알 수 있다. It can be seen that the silkworm collagen health food composition of the present invention is in powder form and is relatively soluble in water.
<항균실험><Antibacterial test>
항균효과를 살펴보기 위해 실시예1 및 실시예2의 건강식품 조성물에 멸균수를 첨가하여 반죽한 다음 실온에서 10일간 방치한 후 일반세균의 수를 측정하였다. 세균수 측정을 위해 5g의 반죽 시료를 채취하여 멸균 균질기로 옮겨서 45mL의 0.5% 펩톤(peptone) 용액에 100초간 혼합하였다. 이 용액을 다시 순차적으로 0.5% 펩톤(peptone) 용액으로 희석하고 희석된 용액 0.1 mL를 plate count agar에 도말하고 35℃에서 배양한 후 그 결과를 하기 표 1에 나타내었다. 제 1시험구는 실시예 1이고, 제 2시험구는 실시예 2이다.In order to examine the antibacterial effect, sterile water was added to the health food composition of Examples 1 and 2, kneaded, and then left at room temperature for 10 days, and then the number of general bacteria was measured. To measure the number of bacteria, 5 g of dough sample was collected, transferred to a sterile homogenizer, and mixed in 45 mL of 0.5% peptone solution for 100 seconds. This solution was again sequentially diluted with 0.5% peptone solution, and 0.1 mL of the diluted solution was spread on a plate count agar and incubated at 35° C. The results are shown in Table 1 below. The first test piece is Example 1, and the second test piece is Example 2.
상기 표 1의 결과를 살펴보면, 참반디추출물이 첨가된 제 2시험구가 제 1시험구에 비해 미생물의 증식을 효과적으로 억제하는 것으로 확인되었다. Looking at the results of Table 1, it was confirmed that the second test group to which the firefly extract was added effectively inhibited the growth of microorganisms compared to the first test group.
이상, 본 발명은 실시 예를 참고로 설명하였으나 이는 예시적인 것에 불과하며, 당해 기술분야에서 통상의 지식을 가진 자라면 이로부터 다양한 변형 및 균등한 실시 예가 가능하다는 점을 이해할 것이다. 따라서 본 발명의 진정한 보호 범위는 첨부된 청구범위에 의해서만 정해져야 할 것이다.As mentioned above, although the present invention has been described with reference to the embodiments, these are merely exemplary, and those of ordinary skill in the art will understand that various modifications and equivalent embodiments are possible therefrom. Accordingly, the true protection scope of the present invention should be defined only by the appended claims.
Claims (6)
어류로부터 추출된 마린콜라겐을 준비하는 제 2단계와;
상기 효소처리누에분말 20 내지 50 중량%, 상기 마린콜라겐 5 내지 40중량%, 비타민C 1 내지 10중량%, 첨가물 30 내지 60중량%를 혼합하는 제 3단계;를 포함하고,
상기 제 1단계는 a)누에를 동결건조시켜 100 내지 300메쉬 입도 크기의 상기 누에분말을 얻는 단계와, b)상기 누에분말을 물에 현탁하여 누에현탁액을 제조하는 단계, c)수산화나트륨 용액 또는 염화수소 용액을 사용하여 상기 누에현탁액의 pH를 5 내지 7로 조정한 다음 단백질 분해효소를 첨가하여 40 내지 70℃에서 1 내지 2일간 가수분해시켜 가수분해물을 수득하는 단계, d)상기 가수분해물을 분무건조시켜 효소처리누에분말을 수득하는 단계를 구비하며,
상기 첨가물은 참반디 추출물이며,
상기 참반디 추출물은 참반디 잎에 물을 중량비로 8배를 가한 후 90℃에서 6시간 동안 추출한 후 여과한 다음 동결건조시켜 수득한 분말인 것을 특징으로 하는 누에콜라겐 건강식품 조성물의 제조방법. A first step of enzymatically treating the silkworm powder to obtain an enzyme-treated silkworm powder;
a second step of preparing marine collagen extracted from fish;
A third step of mixing 20 to 50% by weight of the enzyme-treated silkworm powder, 5 to 40% by weight of the marine collagen, 1 to 10% by weight of vitamin C, and 30 to 60% by weight of additives;
The first step is a) freeze-drying the silkworm to obtain the silkworm powder having a particle size of 100 to 300 mesh, b) suspending the silkworm powder in water to prepare a silkworm suspension, c) sodium hydroxide solution or Adjusting the pH of the silkworm suspension to 5 to 7 using a hydrogen chloride solution, and then hydrolyzing at 40 to 70° C. for 1 to 2 days by adding a proteolytic enzyme to obtain a hydrolyzate, d) spraying the hydrolyzate and drying to obtain an enzyme-treated silkworm powder,
The additive is a firefly extract,
The method for producing a silkworm collagen health food composition, characterized in that the extract is a powder obtained by adding 8 times the weight ratio of water to the firefly leaf, followed by extraction at 90° C. for 6 hours, followed by filtration and freeze-drying.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20180168728 | 2018-12-24 | ||
KR1020180168728 | 2018-12-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200079215A KR20200079215A (en) | 2020-07-02 |
KR102399971B1 true KR102399971B1 (en) | 2022-05-20 |
Family
ID=71599663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190174221A KR102399971B1 (en) | 2018-12-24 | 2019-12-24 | Composition for Silkworm-collagen and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102399971B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102445696B1 (en) * | 2019-11-18 | 2022-09-22 | 대한민국 | Processed boiled and steamed mature silkworm with improved absorption rate and the method thereof |
KR102301569B1 (en) * | 2020-12-03 | 2021-09-13 | 빈희신 | Protein Fortifier Powder Manufacturing Method and Product Containing thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100770686B1 (en) * | 2006-05-22 | 2007-10-29 | 주식회사 브레인가드 | Compositions for treating or preventing diabetes comprising silk peptides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101636680B1 (en) | 2014-05-15 | 2016-07-08 | 주식회사농심 | Method for preparing lowmolecular collagen peptide from fish |
KR101918759B1 (en) | 2017-01-10 | 2018-11-14 | 이병련 | Processed food using freeze-dried silkworm powder and its manufacturing method thereof |
-
2019
- 2019-12-24 KR KR1020190174221A patent/KR102399971B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100770686B1 (en) * | 2006-05-22 | 2007-10-29 | 주식회사 브레인가드 | Compositions for treating or preventing diabetes comprising silk peptides |
Non-Patent Citations (2)
Title |
---|
네이버 블로그에 게재된 ‘마린테크노의 누에콜라겐’(2018.11.20.)* |
네이버 블로그에 게재된 ‘여성단백질, 리즈빈/신도바이오실크’(2017.06.12.)* |
Also Published As
Publication number | Publication date |
---|---|
KR20200079215A (en) | 2020-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2421058C (en) | Protein hydrolysates produced with the use of marine proteases | |
KR101254403B1 (en) | Method for Preparing Fermented Collagen Peptide | |
JP5154964B2 (en) | Contains royal jelly-degrading enzyme | |
KR102148099B1 (en) | Enzyme food composite manufacture method using Isolated Soy Protein and brown rice | |
KR101373940B1 (en) | Method of preparing fermented and enzyme treated silkworm segment extract having high bioactive substances, the silkworm extract obtained thereby, and the use of the silkworm extract having antiinflammatory efficacy | |
KR102399971B1 (en) | Composition for Silkworm-collagen and manufacturing method thereof | |
KR20050057127A (en) | Refined royal jelly | |
Moscoso-Mujica et al. | Antimicrobial peptides purified from hydrolysates of kanihua (Chenopodium pallidicaule Aellen) seed protein fractions | |
RU2331202C1 (en) | Method of production of food protein products | |
JP2008056645A (en) | Anti-oxidant peptide obtained by reaction of protein in enzymatically treated royal jelly with polypeptide and method for producing the same | |
Özyurt et al. | Advances in discard and by-product processing | |
KR20230110470A (en) | A composition for the prevention or treatment of hypertension containing edible insects hydrolysates and fractions thereof | |
KR101973902B1 (en) | Coagulation of soybeans using edible insects and preparation of insect soy sauce using the same | |
JP3615000B2 (en) | Sesame seed-derived protein composition and use thereof | |
KR102581772B1 (en) | A method of optimal cultivation for preparing cultured meat using plant and insect protein hydrolysate and application of the same | |
KR101918692B1 (en) | Flounder surimi with anti-oxidant effect and manufacturing method thereof | |
KR20180065189A (en) | manufacturing method of bread and pastry using marine collagen | |
KR102036864B1 (en) | Hydrolysate of silkworm raised with cudrania tricuspidata leaf, having improved gaba and rutin-enhancing activity, antioxidant activity or inhibitory activity, and preparation method thereof | |
KR102626239B1 (en) | A cosmetic composition containing a sea urchin roe hydrolyzate or a sea urchin roe hydrolyzed fermented product, which has a function of improving wrinkles and regenerating skin, and a method for producing the same | |
KR101694833B1 (en) | Cosmetic composition and food composition including hydrolysate product from silkworm | |
Fawzya et al. | Application of local proteases to produce fish protein hydrolysate (FPH) in Indonesia | |
JP2003102427A (en) | Physiologically functional food material or food and drink having stress stomach ulcer preventing function | |
RU2580157C1 (en) | Method of producing food product having biologically active properties of from hydrobionts | |
JP2003321314A (en) | Antibacterial composition, its manufacturing method and antibacterial agent containing antibacterial composition | |
Mathew et al. | Bioactive Compounds from Marine Sources |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |